Here are some of the best brokerage bonuses and promotions right now. NerdWallet is committed to editorial integrityMany or all of the products on this page are from partners who compensate us when ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
With savings yields expected to diminish in the coming months on the heels of rate cuts from the Federal Reserve, there is another way to earn money with your cash: sign-up bonuses. But with some of ...
(NEXSTAR) – Maybe you caught the Super Bowl ad touting them or heard Nicki Minaj supporting them. Or maybe you’ve been patiently waiting to sign your child up for one. Either way, there’s a new way to ...
Families can now start the process to open Trump accounts for their kids with IRS Form 4547 submitted online via TrumpAccounts.gov. Alternatively, they can include the form when filing 2025 returns ...
Did you know The Athletic has a bunch of email newsletters with millions of subscribers? Well, now you do! Take a look at our offerings below, and sign up to receive them directly in your inbox. 🏆 ...
A rumor that circulated online in November 2025 that Harrison Ford would star in an upcoming live-action version of the animated film "Up" as the film's main character, Carl Fredricksen. Snopes ...
Prince Andrew has announced he will no longer use his title of Duke of York and several royal honours, following ongoing scrutiny of his ties to Jeffrey Epstein and renewed public pressure. Although ...
Oct 10 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to ...
Drugmaker Bristol-Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to diversify from legacy products facing ...
Orbital Therapeutics is currently running IND-enabling studies for its lead candidate. (iStock / Getty Images Plus) The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing ...